Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Feb 28;137(3):706–720. doi: 10.1084/jem.137.3.706

PREVENTION OF CELL-TO-CELL SPREAD OF HERPES SIMPLEX VIRUS BY LEUKOCYTES

Donald Louis Lodmell 1, Akira Niwa 1, Kozaburo Hayashi 1, Abner Louis Notkins 1
PMCID: PMC2139378  PMID: 4347596

Abstract

Antibody to herpes simplex virus (HSV) plus complement destroyed HSV-infected cells but did not stop the spread of the infection. Studies on the relationship between the time of appearance of viral antigens on the cell surface, immunological destruction of the cells by antiviral antibody and complement, and transfer of the virus to adjacent cells showed that the virus spread from infected to uninfected cells before the infected cells were susceptible to immunological destruction. Incubation of infected monolayers with leukocytes, however, stopped the spread of the virus by nonspecifically damaging both infected and uninfected cells and by presumably breaking intercellular bridges. When leukocytes were removed from infected monolayers, viral plaques developed. If, however, antiviral antibody and complement were added to monolayers before the leukocytes were removed, the development of plaques was prevented. These findings suggest that both antibody and leukocytes are needed to cure HSV infections.

Full Text

The Full Text of this article is available as a PDF (1,015.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK F. L., MELNICK J. L. Microepidemiology of poliomyelitis and herpes-B infections: spread of the viruses within tissue cultures. J Immunol. 1955 Mar;74(3):236–242. [PubMed] [Google Scholar]
  2. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med. 1971 May 1;133(5):1090–1104. doi: 10.1084/jem.133.5.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brier A. M., Wohlenberg C., Rosenthal J., Mage M., Notkins A. L. Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3073–3077. doi: 10.1073/pnas.68.12.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christian R. T., Ludovici P. P., Jeter W. S. Cell-to-cell transmission of herpes simplex virus in primary human amnion cells. Proc Soc Exp Biol Med. 1971 Dec;138(3):1109–1115. doi: 10.3181/00379727-138-36061. [DOI] [PubMed] [Google Scholar]
  5. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  6. GLASGOW L. A. LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO. J Exp Med. 1965 Jun 1;121:1001–1018. doi: 10.1084/jem.121.6.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glasgow L. A. Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science. 1970 Nov 20;170(3960):854–856. doi: 10.1126/science.170.3960.854. [DOI] [PubMed] [Google Scholar]
  8. Green J. A., Cooperband S. R., Kibrick S. Immune specific induction of interferon production in cultures of human blood lymphocytes. Science. 1969 Jun 20;164(3886):1415–1417. doi: 10.1126/science.164.3886.1415. [DOI] [PubMed] [Google Scholar]
  9. HOGGAN M. D., ROIZMAN B., ROANE P. R., Jr Further studies of variants of herpes simplex virus that produce syncytia or pocklike lesions in cell cultures. Am J Hyg. 1961 Jan;73:114–122. doi: 10.1093/oxfordjournals.aje.a120162. [DOI] [PubMed] [Google Scholar]
  10. Hampar B., Notkins A. L., Mage M., Keehn M. A. Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol. 1968 Mar;100(3):586–593. [PubMed] [Google Scholar]
  11. Hayashi K., Rosenthal J., Notkins A. L. Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells. Science. 1972 May 5;176(4034):516–518. doi: 10.1126/science.176.4034.516. [DOI] [PubMed] [Google Scholar]
  12. Hirsch M. S., Zisman B., Allison A. C. Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970 May;104(5):1160–1165. [PubMed] [Google Scholar]
  13. Lundstedt C. Interaction between antigenically different cells. Virus-induced cytotoxicity by immune lymphoid cells in vitro. Acta Pathol Microbiol Scand. 1969;75(1):139–152. [PubMed] [Google Scholar]
  14. Mackaness G. B. Cellular immunity. Ann Inst Pasteur (Paris) 1971 Mar;120(3):428–437. [PubMed] [Google Scholar]
  15. Notkins A. L. Infectious virus-antibody complexes: interaction with anti-immunoglobulins, complement, and rheumatoid factor. J Exp Med. 1971 Sep 1;134(3 Pt 2):41s–51s. [PubMed] [Google Scholar]
  16. Oldstone M. B., Dixon F. J. Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. Virology. 1970 Dec;42(4):805–813. doi: 10.1016/0042-6822(70)90330-2. [DOI] [PubMed] [Google Scholar]
  17. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg G. L., Farber P. A., Notkins A. L. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A. 1972 Mar;69(3):756–760. doi: 10.1073/pnas.69.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Snyderman R., Wohlenberg C., Notkins A. L. Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus. J Infect Dis. 1972 Aug;126(2):207–209. doi: 10.1093/infdis/126.2.207. [DOI] [PubMed] [Google Scholar]
  20. Speel L. F., Osborn J. E., Walker D. L. An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection. J Immunol. 1968 Sep;101(3):409–417. [PubMed] [Google Scholar]
  21. Stevens J. G., Cook M. L. Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction. J Exp Med. 1971 Jan 1;133(1):19–38. doi: 10.1084/jem.133.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Todaro G. J., Huebner R. J. N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci U S A. 1972 Apr;69(4):1009–1015. doi: 10.1073/pnas.69.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tompkins W. A., Adams C., Rawls W. E. An in vitro measure of cellular immunity to fibroma virus. J Immunol. 1970 Feb;104(2):502–510. [PubMed] [Google Scholar]
  24. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zisman B., Hirsch M. S., Allison A. C. Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol. 1970 May;104(5):1155–1159. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES